Bayer’s Eylea gets FDA approval for diabetic macular edema treatment
In many countries, aflibercept solution for injection has already been approved as EYLEA to treat patients with neovascular age-related macular degeneration (wet AMD) and visual impairment due to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.